MedTrace Logo

Drug Eluting Balloon (DEB) and Long Lesions of Superficial Femoral Artery (SFA) Ischemic Vascular Disease

NCT01658540 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2016-10-03

No results posted yet for this study

Summary

The primary purpose of this study is to assess safety and efficacy of the Drug Eluting Balloon (DEB) technology for the treatment of the Superficial Femoral Artery (SFA) ischemic obstructive vascular disease in patients presenting with long lesions. As secondary aim this study is going to explore treatment effect on a number of procedural and clinical endpoints in order to collect information to design a future comparative effectiveness study.

Conditions

Sponsors & Collaborators

  • Ettore Sansavini Health Science Foundation

    lead OTHER

Principal Investigators

  • Antonio Micari, MD · Maria Eleonora Hospital, GVM Care & Research

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-05-31
Completion
2016-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01658540 on ClinicalTrials.gov